Association and preferential transmission of the CCR2V641 polymorphism with absence of asthma in high-risk families

Saudi Medical Journal

Volumn 29, Issue 12, 2008, Pages 1711-1718

  Al Abdulhadi, Saleh A ^a,c   Al Rabia, Mohammed W ^b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UMM AL QURA UNIVERSITY   (Saudi Arabia)

^c SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; IMMUNOGLOBULIN E; ISOLEUCINE; METHACHOLINE; VALINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; ATOPY; BRONCHUS HYPERREACTIVITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HIGH RISK POPULATION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PEDIGREE ANALYSIS; PHENOTYPE; PRICK TEST; SCHOOL CHILD; SENSITIZATION; UNITED KINGDOM; UNIVERSITY HOSPITAL;

ADOLESCENT; ALLELES; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR2; YOUNG ADULT;

EID: 60149094989     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Koeppen-Schomerus G, Stevenson J, Plomin R. Genes and environment in asthma: A study of 4 year old twins. Arch Dis Child 2001; 85: 398-400.
2. Haagerup A, Bjerke T, Schiøtz PO, Binderup HG, Dahl R, Kruse TA. Asthma and atopy - a total genome scan for susceptibility genes. Allergy 2002; 57: 680-686.
3. Hall IP, Wheatley A, Christie G, McDougall C, Hubbard R, Helms PJ. Association of CCR5 delta32 with reduced risk of asthma. Lancet 1999; 354: 1264-1265.
4. Nickel R, Beck LA, Stellato C, Schleimer RP. Chemokines and allergic disease. J Allery Clin Immunol 1999; 104 (4 Pt 1): 723-742.
5. Daugherty BL, Springer MS. The beta-chemokine receptor genes CCR1 (CMKBR1), CCR2 (CMKBR2), and CCR3 (CMKBR3) cluster within 285 kb on human chromosome 3p21. Genomics 1997; 41: 294-295.
6. Teran LM. CCL chemokines and asthma. Immunol Today 2000; 21: 235-242.
7. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, Coughlin SR. Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci U S A 1994; 91: 2752-2726.
8. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997; 277: 959-965.
9. Gu L, Tseng S, Horner RM, Tam C, Loda M, Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 2000; 404: 407-411.
10. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, et al. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998; 187: 601-608.
11. Shieh B, Liau YE, Hsieh PS, Yan YP, Wang ST, Li C. Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4. Int Immunol 2000; 12: 1311-1318.
12. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394: 894-897.
13. Wong LM, Myers SJ, Tsou CL, Gosling J, Arai H, Charo IF. Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J Biol Chem 1997; 272: 1038-1045.
14. Monteclaro FS, Charo IF. The amino-terminal domain of CCR2 is both necessary and sufficient for high affinity binding of monocyte chemoattractant protein 1. Receptor activation by a pseudo-tethered ligand. J Biol Chem 1997; 272: 23186-23190.
15. Anzala AO, Ball TB, Rostron T, O'brien SJ, Plummer FA, Rowland-Jones SL. CCR2-64I allele and genotype association with delayed AIDS progression in African women. University of Nairobi Collaboration for HIV Research. Lancet 1998; 351: 1632-1623.
16. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998; 4: 350-353.
17. Dawson B, Horobin G, Illsley R, Mitchell R. Survey of childhood asthma in Aberdeen. Arch Dis Child 1969; 44: 135-136.
18. Christie GL, Helms PJ, Godden DJ, Ross SJ, Friend JA, Legge JS, et al. Asthma, wheezy bronchitis, and atopy across two generations. Am J Respir Crit Care Med 1999; 159: 125-129.
19. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: A method and clinical survey. Clin Allergy 1977; 7: 235-243.
20. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659-664.
21. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Jr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15: 75-88.
22. Eriksson S, Berg LM, Wadelius M, Alderborn A. Cytochrome p450 genotyping by multiplexed real-time dna sequencing with pyrosequencing technology. Assay Drug Dev Technol 2002; 1 (1 Pt 1): 49-59.
23. Martin ER, Monks SA, Warren LL, Kaplan NL. A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 2000; 67: 146-154.
24. Martin ER, Bass MP, Kaplan NL. Correcting for a potential bias in the pedigree disequilibrium test. Am J Hum Genet 2001; 68: 1065-1067.
25. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516
26. Sabroe I, Lloyd CM, Whyte MK, Dower SK, Williams TJ, Pease JE. Chemokines, innate and adaptive immunity, and respiratory disease. Eur Respir J 2002; 19: 350-355.
27. Su B, Jin L, Hu F, Xiao J, Luo J, Lu D, et al. Distribution of two HIV-1-resistant polymorphisms (SDF1-3'A and CCR2-641) in east Asian and world populations and its implication in AIDS epidemiology. Am J Hum Genet 1999; 65: 1047-1053.
28. Morawetz RA, Rizzardi GP, Glauser D, Rutschmann O, Hirschel B, Perrin L, et al. Genetic polymorphism of CCR5 gene and HIV disease: The heterozygous (CCR/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort. Eur J Immunol 1997; 27: 3223-3227.
29. Lee B, Doranz BJ, Rana S, Yi Y, Mellado M, Frade JM, et al. Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4. J Virol 1998; 72: 7450-7458.
30. Ying S, Meng Q, Zeibecoglou K, Robinson DS, Macfarlane A, Humbert M, et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics. J Immunol 1999; 163: 6321-6329.
31. Kim YK, Oh HB, Lee EY, Gho YS, Lee JE, Kim YY. Association between a genetic variation of CC chemokine receptor-2 and atopic asthma. Allergy 2007; 62: 208-209.